Immunohistochemical analysis has identified TFPI2-positive and TFPI2-negative cell populations in malignancies like G3 breast cancer [25], gastric cancer [25], colorectal cancer [25], endometrial cancer [22,25,174], and ovarian cancer [17]. Here, TFPI2 is linked to breast carcinoma.